BASTOS DA SILVA, M., HERION, F., RASKINET, R., DAVID, J. -L., GUSTIN, P., DESSY, C. & LEKEUX, P. (1996). Inhibition of PAF-induced platelet aggregation by WEB 2086 "in-vitro", an antagonist to the receptor for platelet-activating factor, in bovine. Journal of Veterinary Medicine A 43, 399-13.
BASTOS DA SILVA, M., HERION, F., RASKINET, R., DAVID, J. -L., GUSTIN, P. & LEKEUX, P. (1997). Combined effect of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced ex-vivo platelet aggregation in bovine. Journal of Veterinary Medicine A 44, 65-1.
BRUNE, K., GEISSLINGER, G. & MENZEL-SOGLOWEK, S. (1992). Pure enantiomers of 2-arylpropionic acids: tools in pain research and improved drugs in rheumatology. Journal of Clinical Pharmacology 32, 944-52.
CAMBRIDGE, H., LEES, P., SEDGWICK, A. D., HOOKE, R. E., RUSSELL, C., DAWSON, J. & MAY, S. A. (1987). Influence of non-steroidal anti-inflammatory drugs on serum thromboxane and platelet function in horses. British Journal of Pharmacology 92, -623P.
CARGILL, D. I., COHEN, D. S., VAN VALEN, R. G., KLINEK, J. J. & LEVIN, R. P. (1989). Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF). Thrombosis Haemostasis 49, 204-7.
CHAN, W. P. & LEVY, J. V. (1991). Effects of antiplatelet agents on platelet aggregation induced by platelet-activating factor (PAF) in human whole blood. Prostaglandins 42, 337-42.
DAVID, J. -L., MONFORT, F., HERION, F. & RASKINET, R. (1979). Compared effects of three dose-levels of Ticlopodine on platelet function in normal subjects. Thrombosis Research 14, 35-49.
GENTRY, P. A., TREMBLAY, R. R. M. & ROSS, M. L. (1989). Failure of aspirin to impair bovine platelet function. American Journal of Veterinary Research 50, 919-22.
KANTOR, T. G. (1986). Ketoprofen: a review of its pharmacological and clinical properties. Pharmacotherapy 6, 93-102.
LANDOM, M. F., CUNNINGHAM, F. M. & LEES, P. (1995). Pharmacokinetics and pharmacodynamics of ketoprofen in calves applying PK/PD modelling. Journal of Veterinary Pharmacology and Therapeutics 18, 315-324.
LAURI, D., CERLETTI, C. & DE GAETANO, G. (1985). Amplification of primary response of human platelets to platelet-activating factor: Aspirin-sensitive and aspirine-insensitive pathways. Journal of Laboratory and Clinical Medicine 105, 653-658.
LEES, P. & HIGGINS, P. (1985). Clinical pharmacology and therapeutic uses of non-steroidal anti-inflammatory drugs in the horse. Equine Veterinary Journal 17, 83-96.
LEKEUX, P. (1991). Pharmacodynamic. In Le Grand Livre des AINS, pp. 29-37, Delannoy I. (ed.) Schering-Plough Santé Animale , Paris France.
MCALLISTER, C. G., MORGAN, S. J., BORNE, A. T. & POLLET, R. A. (1993). Comparison of adverse effects of phenylbutazone, flunixin meglumine and ketoprofen in horses. Journal of the American Medical Association 202, 71-7.
TWOMEY, B. & DALE, M. (1992). Cyclooxygenase-independent effects of non-steroidal anti-inflammatory drugs on the neutrophil respiratory burst. Biochemical Pharmacology 43, 413-8.
VAN DE WEERDT, M. -L., COGHE, J., UYSTEPRUYST, C., Deby-Dupont, G. & LEKEUX, P. (1997). Ketoprofen and phenylbutazone Attenuation of PAF-induced lung inflammation in calves. Submitted.
VARGAFTIG, B. B., CHIGNARD, M. & BENVENISTE, J. (1981). Present concepts on the mechanisms of platelet aggregation. Biochemical Pharmacology 30, 263-271.
VEYS, E. M. (1991). 20 years' experience with ketoprofen. Scandinavian Journal of Rheumatology 20, 3-44.
VIEIRA, S. (1985). Introdução à Bioestatística. Visira S. (ed). Campus Ltda. 3a. ed. Rio de Janeiro, pp. 223-45. Rio de Janeiro.
